CLINICAL_TRIALS withdrawal · 2013-07-11

Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer [Phase 2]

A Phase 2 trial evaluating peripheral stem cell transplantation for metastatic or recurrent renal cell carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Fox Chase Cancer Center | Conditions: Kidney Cancer | Phase 2 | Status: WITHDRAWN